Free public records show Umedica in 1 of the markets we cover. It is not a key player in our research.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
16 approvals with a product on the US market
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
Markets we cover where free public records show Umedica: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Umedica is in.
Stories on the topics Umedica works in.
Only about a quarter of testosterone booster products had study data showing they raise testosterone. Sexual…
Read
About 1 in 6 adults experience infertility. In many countries one IVF cycle costs more than a year's income.
Read
In 2022 the FDA approved the first pill for severe alopecia areata, which affects more than 300,000 people in…
Read